The short version of GLP-1 receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-09. Anything still debated is marked as such rather than presented as settled.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Includes the 39-residue backbone and the attached fatty diacid |
| Molecular weight | Approximately 4813 Da | Average mass; the monoisotopic value is slightly lower |
| Receptor targets | GIP receptor and GLP-1 receptor | Dual engagement defines the pharmacological class |
| Backbone length | 39 amino acids | Sequence modified from native glucose-dependent insulinotropic polypeptide |
| Albumin interaction | Reversible, mediated by the fatty diacid | Slows renal clearance and lengthens circulation time |
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
After the injection the person's hand is wrapped in bulky gauze dressing and must be elevated for the rest of the day. After 24 hours the person returns for passive digital extension to rupture the cord. Moderate pressure for 10–20 seconds ruptures the cord. After the treatment with collagenase the person should use a night splint and perform digital flexion/extension exercises several times per day for 4 months.
An enkephalinase inhibitor is a type of enzyme inhibitor which inhibits one or more members of the enkephalinase class of enzymes that break down the endogenous enkephalin opioid peptides. Examples include racecadotril, ubenimex (bestatin), RB-101, and D-phenylalanine, as well as the endogenous opioid peptides opiorphin and spinorphin. It also includes RB-3007, Semax and Selank. Analgesic, anticraving, antidepressant, anxiolytic, and antidiarrheal effects are common properties of enkephalinase inhibitors.
== Side effects == While botulinum toxin is generally considered safe in a clinical setting, serious side effects from its use can occur. Most commonly, botulinum toxin can be injected into the wrong muscle group or with time spread from the injection site, causing temporary paralysis of unintended muscles. In at least three cases temporary diplopia was reported due to subcutaneous injections for cosmetic purposes. Side effects from cosmetic use generally result from unintended paralysis of facial muscles. These include partial facial paralysis, muscle weakness, and trouble swallowing. Side effects are not limited to direct paralysis, however, and can also include headaches, flu-like symptoms, and allergic reactions. Just as cosmetic treatments only last a number of months, paralysis side effects can have the same durations. At least in some cases, these effects are reported to dissipate in the weeks after treatment. Bruising at the site of injection is not a side effect of the toxin, but rather of the mode of administration, and is reported as preventable if the clinician applies pressure to the injection site; when it occurs, it is reported in specific cases to last 7–11 days. When injecting the masseter muscle of the jaw, loss of muscle function can result in a loss or reduction of power to chew solid foods. With continued high doses, the muscles can atrophy or lose strength; research has shown that those muscles rebuild after a break from Botox.
On 5 October 2018, Singapore carried out three executions of drug traffickers - Zainudin bin Mohamed, Abdul Wahid Bin Ismail, and Mohsen Bin Na’im, it led to the Asian Forum for Human Rights and Development (FORUM-ASIA) and 28 civil society organizations in Asia showing condemnation over the triple hangings, and these groups the death sentence was a grave violation of the right to life, which was "the most fundamental and essential human right for other rights to be realized". They also argued that the executions of Zainudin, Abdul Wahid and Mohsen did not serve any purpose for the island-state and its citizens in terms of fulfilling the ends of justice. In March 2022, when Singapore dismissed the final appeal of Malaysian death row prisoner Nagaenthran K. Dharmalingam and later authorized the execution of Singaporean drug convict Abdul Kahar Othman, which was its first execution during the COVID-19 pandemic, there were 400 Singaporeans, including rights activists Jolovan Wham, Kirsten Han and Kokila Annamalai, who took part in a protest against the government's use of the death penalty at Hong Lim Park. With regards to Abdul Kahar's execution, the European Union (EU) condemned it and stated that capital punishment is a cruel and inhumane punishment, which not only failed to deter crime but also defied both humanity's dignity and integrity. Two days prior to Nagaenthran's execution (which took place on 27 April 2022), a candlelight vigil was held on his behalf.
=== Beginnings === Chromosomes were first observed in plant cells by Carl Nägeli in 1842. Their behavior in animal (salamander) cells was described by Walther Flemming, the discoverer of mitosis, in 1882. The name was coined by another German anatomist, von Waldeyer in 1888. The next stage took place after the development of genetics in the early 20th century, when it was appreciated that the set of chromosomes (the karyotype) was the carrier of the genes. Levitsky seems to have been the first to define the karyotype as the phenotypic appearance of the somatic chromosomes, in contrast to their genic contents. Investigation into the human karyotype took many years to settle the most basic question: how many chromosomes does a normal diploid human cell contain? In 1912, Hans von Winiwarter reported 47 chromosomes in spermatogonia and 48 in oogonia, concluding an XX/XO sex determination mechanism. Painter in 1922 was not certain whether the diploid number of humans was 46 or 48, at first favoring 46. He revised his opinion later from 46 to 48, and he correctly insisted on humans having an XX/XY system of sex-determination. Considering their techniques, these results were quite remarkable. In science books, the number of human chromosomes remained at 48 for over thirty years. New techniques were needed to correct this error. Joe Hin Tjio working in Albert Levan's lab was responsible for finding the approach:
Sources: en.wikipedia.org
Newsweek posted an article about Cheese, titled "Stopping a Kid Killer," in 2007. Jack Schafer, a columnist for Slate, criticized the Newsweek article; Schafer believes that the Newsweek article does not adequately explain the process of creating Cheese and did not use scientists as sources. Jane C. Maxwell, a senior research scientist of the Gulf Coast Addiction Technology Transfer Center at The University of Texas at Austin, stated in "“Cheese” Heroin: Status as of May 2, 2007" that she believes that the effect of Cheese could increase due to media reporting aspects such as "unsubstantiated numbers" and "sensationalistic emphasis" regarding "new highs" and "schoolboy drugs," leading to copycat outbreaks. In mid-2007, a number of area stores opted either to remove Tylenol PM and similar products from their shelves or to move them to shelves within a pharmacist's view or control. The manager of a Fiesta Mart supermarket in northwest Dallas explained his store's policy shift regarding various diphenhydramine-containing products by saying local youths were stealing these items, adding, "We didn't want to be part of the problem or anybody dying," implying that the store also pulled the products to curb abuse. The manager stated that theft decreased after removing the products, and various local Carnival supermarkets and Walgreens pharmacies also voluntarily shifted the products to pharmacist-controlled or -monitored shelves. The Dallas Morning News unofficially reported that arrests for Cheese in DISD decreased.
In 2019, NCCD became the knowledge partner for the International Solar Alliance to help foster solar energy used in cold chains in its UN member countries. Through NCCD, various myths about India's cold storage sector were rectified and it brought about a paradigm shift in policies. NCCD was awarded the Agribusiness Leadership Award in India in 2014. In 2018, in recognition of the individual contributions of then CEO of NCCD, the University of Birmingham conferred him the title of honorary Professor. Through five technical committees constituted under NCCD, various domain experts within the country are also able to contribute in the works undertaken by NCCD. These include training in cold chain operations, workshops to encourage policy level interface between decision makers in government and operators, as well as knowledge dissemination through capacity building and awareness programmes. NCCD is recognized as the nodal body for cold chain development in India and for its unique construct, as an ecosystem of public and private sector stakeholders that serves to provide the country context relevant direction for its initiatives to develop cold chain for its agricultural sector.
C. Judson King is an American chemical engineer, researcher, administrator and educator. He is professor emeritus at University of California, Berkeley, and UC universitywide provost and senior vice president of academic affairs, emeritus, at University of California. He is the former director of Center for Studies in Higher Education and the former dean of College of Chemistry at UC Berkeley. King's research has been focused in two areas: chemical engineering and higher education. In the area of chemical engineering, he has conducted considerable research on spray drying, freeze drying, and removal and recovery of organic pollutants from wastewater streams. In the area of higher education he has written about university structure and governance, innovation in universities, and engineering education. He has written three books and over 250 scientific articles. He holds 13 patents. King has received many awards for his contribution to the field of chemical engineering. He was elected to the National Academy of Engineering in 1981 for distinguished contributions to freeze-drying technology, systematic studies of chemical-process synthesis, and chemical engineering education. He became a fellow of the American Institute of Chemical Engineers in 1983, and a fellow of the American Association for the Advancement of Science in 1993. In 2009, the American Institute of Chemical Engineers named him one of the 100 Chemical Engineers of the Modern Era.
VHF omnidirectional range (VOR) – a worldwide aircraft radio navigation system consisting of fixed ground radio beacons transmitting between 108.00 and 117.95 MHz in the very high frequency (VHF) band. An automated navigational instrument on the aircraft displays a bearing to a nearby VOR transmitter. A VOR beacon transmits two signals simultaneously on different frequencies. A directional antenna transmits a beam of radio waves that rotates like a lighthouse at a fixed rate, 30 times per second. When the directional beam is facing north, an omnidirectional antenna transmits a pulse. By measuring the difference in phase of these two signals, an aircraft can determine its bearing (or "radial") from the station accurately. By taking a bearing on two VOR beacons an aircraft can determine its position (called a "fix") to an accuracy of about 90 metres (300 ft). Most VOR beacons also have a distance measuring capability, called distance measuring equipment (DME); these are called VOR/DME's. The aircraft transmits a radio signal to the VOR/DME beacon and a transponder transmits a return signal. From the propagation delay between the transmitted and received signal the aircraft can calculate its distance from the beacon. This allows an aircraft to determine its location "fix" from only one VOR beacon. Since line-of-sight VHF frequencies are used VOR beacons have a range of about 200 miles for aircraft at cruising altitude. TACAN is a similar military radio beacon system which transmits in 962–1213 MHz, and a combined VOR and TACAN beacon is called a VORTAC.
Sources: en.wikipedia.org
=== Non-human models === Azvudine is found to be mutagenic in in vitro in the Ames test, CHL test, and in vitro in the mice micronucleus test. Azvudine is toxic to the reproductive system of rats and rabbit. The minimum reproductive NOAEL found for males is 5.0 mg/kg/d and for females 0.5 mg/kg/d. It is excreted in rat breast milk; the NOAEL for rat pups is 1.5 mg/kg/d. Azvudine is mainly toxic to the immune system, bone marrow, and digestive system of model animals. The chronic NOAELs are 0.5 mg/kg/d (rat, 3 months), 0.3 mg/kg/d (rat, 26 weeks), and 0.1 mg/kg/d (beagle dog, 1 month and 39 weeks). For comparison, the chronic human dose for HIV treatment is 0.05 mg/kg/d, using the reference 3 mg dose and an average Chinese body mass of 59.5 kg (2014).
=== Homoleptic complexes (only amino acid ligands) === Mixing simple metal salts with solutions of amino acids near neutral or elevated pH often affords bis- or tris complexes. For metal ions that prefer octahedral coordination, these complexes often adopt the stoichiometry M(aa)3 (aa = amino carboxylate, such as glycinate, H2NCH2CO2−). Complexes of the 3:1 stoichiometry have the formula [M(O2CC(R)HNH2)3]z. Such complexes adopt octahedral coordination geometry. These complexes can exist in facial and meridional isomers, both of which are chiral. The stereochemical possibilities increase when the amino acid ligands are not homochiral. Both the violet meridional and red-pink facial isomers of tris(glycinato)cobalt(III) have been characterized With L-alanine, L-leucine, and other amino acids, one obtains four stereoisomers. With cysteine, the amino acid binds through N and thiolate. Complexes with the 2:1 stoichiometry are illustrated by copper(II) glycinate [Cu(O2CC(R)HNH2)2], which akso exists as a pentacoordinate monohydrate. When the metal is square planar, these complexes can exist as cis and trans isomers. The stereochemical possibilities increase when the amino acid ligands are not homochiral. Homoleptic complexes are also known where the amino carboxylate is tridentate amino acids. One such complex is Ni(κ3-histidinate)2.
Bohr's theory was vindicated by the discovery of element 72: Georges Urbain claimed to have discovered it as the rare earth element celtium, but Bury and Bohr had predicted that element 72 could not be a rare earth element and had to be a homologue of zirconium. Dirk Coster and Georg von Hevesy searched for the element in zirconium ores and found element 72, which they named hafnium after Bohr's hometown of Copenhagen (Hafnia in Latin). Urbain's celtium proved to be simply purified lutetium (element 71). Hafnium and rhenium thus became the last stable elements to be discovered. Prompted by Bohr, Wolfgang Pauli took up the problem of electron configurations in 1923. Pauli extended Bohr's scheme to use four quantum numbers, and formulated his exclusion principle which stated that no two electrons could have the same four quantum numbers. This explained the lengths of the periods in the periodic table (2, 8, 18, and 32), which corresponded to the number of electrons that each shell could occupy. In 1925, Friedrich Hund arrived at configurations close to the modern ones. As a result of these advances, periodicity became based on the number of chemically active or valence electrons rather than by the valences of the elements. The Aufbau principle that describes the electron configurations of the elements was first empirically observed by Erwin Madelung in 1926, though the first to publish it was Vladimir Karapetoff in 1930.
=== Synthesis of lithium-titanate breeder powder === Li2TiO3 powder is most commonly prepared by the mixing of lithium carbonate, Ti-nitrate solution, and citric acid followed by calcination, compaction, and sintering. The nanocrystalline material created is used as a breeder powder due to its high purity and activity.
A research study that compares a particular outcome in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke). (NCI) Community-based clinical trial (CBCT)
Sources: en.wikipedia.org
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.
Engaging two receptors recruits signaling pathways that only partly coincide. This can shift the magnitude of effects on insulin release, glucagon levels and appetite relative to selective agents. Whether the pairing delivers benefits beyond a simple sum of the two is still debated in the literature.
The proportional contribution of each receptor to observed clinical effects has not been fully separated. Long-term consequences of continuous dual stimulation are likewise unclear. Investigators continue to probe these points through laboratory and clinical work.
It is a dual GIP and GLP-1 receptor agonist, frequently grouped with incretin-based peptide therapeutics. It is a peptide rather than a small molecule and is given by subcutaneous injection.